Please provide your email address to receive an email when new articles are posted on . LivaNova announced it received regulatory approvals and has initiated a targeted commercial launch if its ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance ...
Registration as a Clinical Perfusion Trainee through the Australian and New Zealand College of Perfusionists (ANZCP) trainee pathway (mandatory). A strong foundation in health and science through a ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion ...
With Penn State IRB approval and parental informed consent, and under the guidance of a Data Safety Medical Board (DSMB) in addition to FDA clinicaltrials.com database registration, 238 patients were ...
First-ever dual-flow device designed to prevent severe vascular complications and amputations when performing critical heart and lung life-support techniques (ECMO and CPB) Innovation driven by ...
“The Essenz Perfusion System has tremendous potential to become a key addition to our clinical practice, fusing a new era of technology with the skill and expertise of the perfusionist,” said Larry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results